Male Hypogonadism: Childhood Diagnosis and Future Therapies

• Layman LC : Hypogonadotropic hypogonadism.Endocrinol. Metab. Clin. N. Am.36, 283–296(2007).
   PubMed Web of Science ®Google Scholar
• Bianco SD , KaiserU: The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.Nat. Rev. Endocrinol.5(10), 569–576(2009).
   PubMed Web of Science ®Google Scholar
• Viswanathan V , EugsterEA: Etiology and treatment of hypogonadism in adolescents.Endocrinol. Metab. Clin. N. Am.38, 719–738(2009).
   PubMed Web of Science ®Google Scholar
• Raivio T , FalardeauJ, DwyerAet al.: Reversal of idiopathic hypogonadotropic hypogonadism.N. Engl. J. Med.357, 863–873(2007).
   PubMed Web of Science ®Google Scholar
• Grumbach MM : Commentary: A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant.J. Clin. Endocrinol. Metab.90, 3122–3127(2005).
   PubMed Web of Science ®Google Scholar
• Wierman ME , PawlowskiJE, AllenMP, XuM, LinsemanDA, Nielsen-PreissS: Molecular mechanisms of gonadotropin-releasing hormone neuronal migration.Trends Endocrinol. Metab.15(3), 96–102(2004).
   PubMed Web of Science ®Google Scholar
• Grinspon RP , ReyRA: Anti-Müllerian hormone and sertoli cell function in paediatric male hypogonadism.Horm. Res. Paediatr.73(2), 81–92(2010).
   PubMed Web of Science ®Google Scholar
• Crofton PM , EvansAEM, GroomeNP, TaylorMRH, HollandCV, KelnartCJH: Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone.Clin. Endocrinol.56, 215–221(2002).
   PubMed Web of Science ®Google Scholar
• Sharpe RM , McKinnellC, KivlinC, FisherJS: Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood.Reproduction125, 769–784(2003).
   PubMed Web of Science ®Google Scholar
• MacLaughlin , DT, Donahoe PK: Sex determination and differentiation. N. Engl. J. Med.350, 367–378(2004).
   PubMed Web of Science ®Google Scholar
• Tsang S : When size matters: a clinical review of pathological micropenis.J. Pediatr. Health Care24(4), 231–240(2010).
   PubMed Web of Science ®Google Scholar
• Hughes IA , AceriniCL: Factors controlling testis descent.Eur. J. Endocrinol.159(Suppl. 1), S75–S82 (2008).
   PubMed Web of Science ®Google Scholar
• Mendonca BB , InacioM, ArnholdIJet al.: Male pseudohermaphroditism due to 17 β-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management.Medicine (Baltimore)79(5), 299–309(2000)
   PubMed Web of Science ®Google Scholar
• Latronico AC : The neurokinin B pathway in human reproduction.Nature Genetics41, 269–270(2009).
   PubMed Web of Science ®Google Scholar
• Trarbach EB , SilveiraLG, LatronicoAC: Genetic insights into human isolated gonadotropin deficiency.Pituitary10(4), 381–391(2007).
   PubMed Web of Science ®Google Scholar
• Mehta A , DattaniMT: Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism.Best Pract. Res. Clin. Endocrinol. Metab.22(1), 191–206(2008).
   PubMed Web of Science ®Google Scholar
• Zentner GE , LaymanWS, MartinDM, ScacheriPC: Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome.Am. J. Med. Genet. A.22, 152(3), 674–686 (2010).
   Google Scholar
• Jongmans MCJ , van Ravenswaaij-Arts CMA, Pitteloud N et al.: CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndrome. Clin. Genet.75, 65–71(2009).
   PubMed Web of Science ®Google Scholar
• Ribeiro RS , VieiraTC, AbuchamJ: Reversible Kallmann syndrome: report of the first case with a KAL1 mutation and literature review.Eur. J. Endocrinol.156(3), 285–290(2007).
   PubMed Web of Science ®Google Scholar
• Sinisi AA , AsciR, BellastellaGet al.: Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.Hum. Reprod.23(10), 2380–2384(2008).
   PubMed Web of Science ®Google Scholar
• Pitteloud N , MeysingA, QuintonRet al.: Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.Mol. Cell. Endocrinol.25, 254–255:60–69 (2006).
   Google Scholar
• Gianetti E , TussetC, NoelSDet al.: TAC3/TACR3 mutations reveal preferential activation of GnRH release 1 by neurokinin B2 in neonatal life followed by reversal in adulthood.J. Clin. Endocrinol. Metab.95(6), 2857–2867(2010).
   PubMed Web of Science ®Google Scholar
• Semple RK , TopalogluA: The recent genetics of hypogonadotrophic hypogonadism – novel insights and new questions.Clin. Endocrinol. (Oxf.).72(4), 427–435(2010).
   PubMed Web of Science ®Google Scholar
• Bittel DC , ButlerMG: Prader–Willi syndrome: clinical genetics, cytogenetics and molecular biology.Expert Rev. Mol. Med.25, 1–20(2005).
   Google Scholar
• de Smith AJ , PurmannC, WaltersRGet al.: A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism.Hum. Mol. Genet.18(17), 3257–3265(2009).
   PubMed Web of Science ®Google Scholar
• Merchant TE , WilliamsT, SmithJMet al.: Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function.Int. J. Radiat. Oncol. Biol. Phys.54(1), 45–50(2002).
   PubMed Web of Science ®Google Scholar
• Gonc EN , YordamN, OzonA: Endocrine outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.Pediatr. Neurosurg.40, 112–119(2004).
   PubMed Web of Science ®Google Scholar
• Knoepfelmacher M , GomesMC, MeloME, MendoncaBB: Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma.Pituitary7(2), 83–87(2004).
   PubMedGoogle Scholar
• Acerini CL , TaskerRC: Endocrine sequelae of traumatic brain injury in childhood.Horm. Res.68(5), 14–17(2007).
   PubMedGoogle Scholar
• Schneider HJ , CorneliG, Kreitschman-AndermahrIet al.: Traumatic brain injury and hypopituitarism in children and adolescents: is the problem under-estimated?Pediatr. Endocrinol. Rev.4(3), 205–209(2007).
   PubMedGoogle Scholar
• Mouritsen A , AksglaedeL, S⊘rensenKet al.: Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty.Int. J. Androl.33(2), 346–359(2010).
   PubMedGoogle Scholar
• Soneda S , FukamiM, FujimotoM, HasegawaT, KoitabashiY, OgataT: Association of micropenis with Pro185Ala polymorphism of the gene for aryl hydrocarbon receptor repressor involved in dioxin signaling.Endocr. J.52(1), 83–88(2005).
   PubMed Web of Science ®Google Scholar
• Wikström AM , DunkelL: Testicular function in Klinefelter syndrome.Horm. Res.69(6), 317–326(2008).
   PubMedGoogle Scholar
• Bastida MG , ReyRA, BergadáIet al.: Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome.Clin. Endocrinol.(Oxf.)67(6), 863–870(2007).
   PubMed Web of Science ®Google Scholar
• Lanfranco F , KamischkeA, ZitzmannM, NieschlagE: Klinefelter‘s syndrome.Lancet364, 273–283(2004).
   PubMed Web of Science ®Google Scholar
• Ross JL , RoeltgenDP, StefanatosGet al.: Cognitive and motor development during childhood in boys with Klinefelter syndrome.Am. J. Med. Genet.146A(6), 708–719(2008).
   PubMed Web of Science ®Google Scholar
• Bruining H , SwaabH, KasM, van Engeland H: Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics123(5), e865–e870 (2009).
   PubMed Web of Science ®Google Scholar
• Lindstedt G , NyströmE, MatthewsC, ErnestI, JansonPO, ChatterjeeK: Follitropin (FSH) deficiency in an infertile male due to FSHb gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations.Clin. Chem. Lab. Med.36(8), 663–665(1998).
   PubMed Web of Science ®Google Scholar
• Weiss J , AxelrodL, WhitcombRW, HarrisPE, CrowleyWF, JamesonJL: Hypogonadism caused by a single amino acid substitution in the β subunit of luteinizing hormone.N. Engl. J. Med.326(3), 179–178(1992).
   PubMed Web of Science ®Google Scholar
• Perniola R , FalorniA, ClementeMG, ForiniF, AccogliE, LobreglioG: Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).Eur. J. Endocrinol.143(4), 497–503(2000).
   PubMed Web of Science ®Google Scholar
• Sinisi AA , D‘ApuzzoA, PasqualiD, VendittoTet al.: Antisperm antibodies in prepubertal boys treated with chemotherapy for malignant or non-malignant diseases and in boys with genital tract abnormalities.Int. J. Androl.20(1), 23–28(1997).
   PubMedGoogle Scholar
• Webb EA , DattaniMT: Septo-optic dysplasia.Eur. J. Hum. Genet.18(4), 393–397, (2010)
   PubMed Web of Science ®Google Scholar
• Sedlmeyer IL , PalmertMR: Delayed puberty: analysis of a large case series from an academic center.J. Clin. Endocrinol. Metab.87, 1613–1620(2002).
   PubMed Web of Science ®Google Scholar
• Palmert MR , BoepplePA: Variation in the timing of puberty: clinical spectrum and genetic investigation.J. Clin. Endocrinol. Metab.86, 2364–2368(2001).
   PubMed Web of Science ®Google Scholar
• Ghai K , CaraJF, RosenfieldRL: Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys - a clinical research center study.J. Clin. Endocrinol. Metab.80(10), 2980–2986(1995)
   PubMed Web of Science ®Google Scholar
• Partsch CJ , HermanussenM, SippellWG: Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.J. Clin. Endocrinol. Metab.60, 1196–1203(1985)
   PubMed Web of Science ®Google Scholar
• Wilson DA , HofmanPL, MilesHL, UnwinKE, McGrailCE, CutfieldWS: Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.J. Pediatr.148(1), 89–94(2006).
   PubMed Web of Science ®Google Scholar
• Apter D : Ultrasensitive new immunoassays for gonadotropins in the evaluation of puberty:Curr. Opin. Pediatr.5(4), 481–487(1993).
   PubMedGoogle Scholar
• Brito VN , BatistaMC, BorgesMFet al.: Diagnostic value of fluorometric assays in the evaluation of precocious puberty.J. Clin. Endocrinol. Metab.84, 3539–3544(1999).
   PubMed Web of Science ®Google Scholar
• Neely EK , HintzRL, WilsonDMet al.: Normal ranges for immunochemiluminometric gonadotropin assays.J. Pediatr.127(1), 40–46(1995).
   PubMed Web of Science ®Google Scholar
• Resende EA , LaraBH, ReisJD, FerreiraBP, PereiraGA, BorgesMF: Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children.J. Clin. Endocrinol. Metab.92(4), 1424–1429(2007).
   PubMed Web of Science ®Google Scholar
• Bourguignon JP , Vanderschueren-LodeweyckxM, WolterRet al.: and idiopathic delayed puberty: a longitudinal study in an attempt to diagnose gonadotropin deficiency before puberty:J. Clin. Endocrinol. Metab.54(4), 733–744(1982).
   PubMed Web of Science ®Google Scholar
• Berger K , CarvalhoLRS, BritoVNet al.: Predictive value of gonadotropin measurements by fluorometric method after GnRH test in the diagnosis of hypogonadotropic hypogonadism (HH) at prepuberal age. Presented at: The Endocrine Society‘s 85th Annual Meeting. PA, USA. Program & Abstract, 601–601.32 (2003)
   Google Scholar
• Kauschansky A , DickermanZ, PhillipM, WeintrobN, StrichD: Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys.Clin. Endocrinol. (Oxf.)56, 603–607(2002).
   PubMed Web of Science ®Google Scholar
• Degros V , Cortet-RudelliC, SoudanB, DewaillyD: The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty.Eur. J. Endocrinol.149, 23–29(2003).
   PubMed Web of Science ®Google Scholar
• Segal TY , MehtaA, AnazodoA, HindmarshPC, DattaniMT: Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty.J. Clin. Endocrinol. Metab.94(3), 780–785(2009).
   PubMed Web of Science ®Google Scholar
• Marshall WA , TannerJM: Variations in pattern of pubertal changes in girls.Arch. Dis. Child44, 291–303(1969)
   PubMed Web of Science ®Google Scholar
• Marshall WA , TannerJM: Variations in the pattern of pubertal changes in boys.Arch. Dis. Child45, 13–23(1970).
   PubMed Web of Science ®Google Scholar
• Goji K , TanikazeS: Comparison between spontaneous gonadotropin concentration profiles and gonadotropin response to low-dose gonadotropin-releasing hormone in prepubertal and early pubertal boys and patients with hypogonadotropic hypogonadism: assessment by using ultrasensitive, time-resolved immunofluorometric assay.Pediatr. Res.31(5), 535–539(1992).
   PubMed Web of Science ®Google Scholar
• Partsch CJ , HermanussenM, SippellWG: Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.J. Clin. Endocrinol. Metab.60, 1196–1203(1985).
   PubMed Web of Science ®Google Scholar
• Zevenhuijzen H , KelnarCJ, CroftonPM: Diagnostic utility of a low-dose gonadotropin-releasing hormone test in the context of puberty disordersHorm. Res.62(4), 168–176(2004).
   PubMedGoogle Scholar
• Mainieri AS , ElnecaveRH: Usefulness of the free α-subunit to diagnose hypogonadotropic hypogonadism.Clin. Endocrinol. (Oxf.)9(3), 307–313(2003).
   Google Scholar
• Wilson DA , HofmanPL, MilesHL, UnwinKE, McGrailCE, CutfieldWS: Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty.J. Pediatr.148(1), 89–94(2006).
   PubMed Web of Science ®Google Scholar
• Han TS , BoulouxPM: What is the optimal therapy for young males with hypogonadotrophic hypogonadism?Clin. Endocrinol. (Oxf.)72(6), 731–737(2010).
   PubMed Web of Science ®Google Scholar
• Mendonca BB , DomeniceS, ArnholdIJ, CostaEM: 46,XY disorders of sex development (DSD).Clin. Endocrinol. (Oxf.)70(2), 173–187(2009).
   PubMed Web of Science ®Google Scholar
• Thorsson AV , ChristiansenP, RitzénM: Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art.Acta. Paediatrica.96, 628–630(2007).
   PubMed Web of Science ®Google Scholar
• Ritzén EM , BerghA, BjerknesR, ChristiansenPet al.: Nordic consensus on treatment of undescended testes.Acta Paediatrica96, 638–643(2007).
   PubMed Web of Science ®Google Scholar
• Shulman DI , FrancisGL, PalmertMR, Eugster EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee: Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics121(4), 975–983(2008).
   Web of Science ®Google Scholar
• Raivio T , WikströmAM, DunkelL: Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome.Eur. J. Endocrinol.156, 105–111(2007).
   PubMed Web of Science ®Google Scholar
• Bougnères P , FrançoisM, PantaloneLet al.: Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone.J. Clin. Endocrinol. Metab.93, 2202–2205(2008).
   PubMed Web of Science ®Google Scholar
• Main KM , SchmidtIM, ToppariJ, SkakkebaekNE: Early postnatal treatment of hypogonadotropic hypogonadism with recombinant human FSH and LH.Eur. J. Endocrinol.146(1), 75–79(2002).
   PubMed Web of Science ®Google Scholar
• Paduch DA , BolyakovA, CohenP, TravisA: Reproduction in men with Klinefelter syndrome: the past, the present, and the future.Semin. Reprod. Med.27(2), 137–148(2009).
   PubMed Web of Science ®Google Scholar
• Jayasena CN , DhilloWS: Kisspeptin offers a novel therapeutic target in reproduction.Curr. Opin. Investig. Drugs10(4), 311–318(2009).
   PubMedGoogle Scholar
• Plant TM , RamaswamyS, Di Pietro M: Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology147, 1007–1013(2006).
   PubMed Web of Science ®Google Scholar
• Seminara SB , DipietroMJ, RamaswamyS, CrowleyWF Jr, Plant TM: Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology147(5), 2122–2126(2006).
   PubMedGoogle Scholar
• Patterson M , MurphyKG, ThompsonEL, PatelS, GhateiMA, BloomSR: Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats.J. Neuroendocrinol.18(5), 349–354(2006).
   PubMed Web of Science ®Google Scholar

Website

• Centers for Disease Control and Prevention www.cdc.gov/growthchartscity
   Google Scholar